More Argenica Therapeutics Ltd news Argenica Therapeutics LtdASX: AGN ARG-007 Inhibits Cause of Alzheimer's in Pre-Clinical Study Nov 3, 2023 at 3:23 AM UTC · Issued by Argenica Therapeutics Ltd As issuedPlain English Argenica Therapeutics Ltd has released a press release. View Attachment